The risk of ventricular arrhythmias in a Dutch CRT population: CRT-defibrillator versus CRT-pacemaker
- PMID: 26797979
- PMCID: PMC4771627
- DOI: 10.1007/s12471-015-0800-8
The risk of ventricular arrhythmias in a Dutch CRT population: CRT-defibrillator versus CRT-pacemaker
Abstract
Background: Patients eligible for cardiac resynchronisation therapy (CRT) have an indication for primary prophylactic implantable cardioverter defibrillator (ICD) therapy. However, response to CRT might influence processes involved in arrhythmogenesis and therefore change the necessity of ICD therapy in certain patients.
Method: In 202 CRT-defibrillator patients, the association between baseline variables, 6-month echocardiographic outcome (volume response: left ventricular end-systolic volume decrease < ≥15 % and left ventricular ejection fraction (LVEF) ≤ >35 %) and the risk of first appropriate ICD therapy was analysed retrospectively.
Results: Fifty (25 %) patients received appropriate ICD therapy during a median follow-up of 37 (23-52) months. At baseline ischaemic cardiomyopathy (hazard ratio (HR) 2.0, p = 0.019) and a B-type natriuretic peptide level > 163 pmol/l (HR 3.8, p < 0.001) were significantly associated with the risk of appropriate ICD therapy. After 6 months, 105 (52 %) patients showed volume response and 51 (25 %) reached an LVEF > 35 %. Three (6 %) patients with an LVEF > 35 % received appropriate ICD therapy following echocardiography at ± 6 months compared with 43 patients (29 %) with an LVEF ≤ 35 % (p = 0.001). LVEF post-CRT was more strongly associated to the risk of ventricular arrhythmias than volume response (LVEF > 35 %, HR 0.23, p = 0.020).
Conclusion: Assessing the necessity of an ICD in patients eligible for CRT remains a challenge. Six months post-CRT an LVEF > 35 % identified patients at low risk of ventricular arrhythmias. LVEF might be used at the time of generator replacement to identify patients suitable for downgrading to a CRT-pacemaker.
Keywords: Appropriate ICD; Cardiac resynchronisation therapy; Ventricular arrhythmias.
Figures
Similar articles
-
Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.Circulation. 2014 Dec 23;130(25):2278-86. doi: 10.1161/CIRCULATIONAHA.114.011283. Epub 2014 Oct 9. Circulation. 2014. PMID: 25301831 Clinical Trial.
-
Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias.Circ Arrhythm Electrophysiol. 2013 Apr;6(2):257-64. doi: 10.1161/CIRCEP.112.000214. Epub 2013 Feb 26. Circ Arrhythm Electrophysiol. 2013. PMID: 23443618
-
Normalization of Left Ventricular Ejection Fraction and Incidence of Appropriate Antitachycardia Therapy in Patients With Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Death.J Card Fail. 2016 Feb;22(2):125-32. doi: 10.1016/j.cardfail.2015.10.015. Epub 2015 Nov 11. J Card Fail. 2016. PMID: 26522819
-
Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy : An updated meta-analysis and effect on Dutch clinical practice by the Task Force of the Dutch Society of Cardiology.Neth Heart J. 2023 Mar;31(3):89-99. doi: 10.1007/s12471-022-01718-3. Epub 2022 Sep 6. Neth Heart J. 2023. PMID: 36066840 Free PMC article. Review.
-
Meta-analysis of Risk of Ventricular Arrhythmias After Improvement in Left Ventricular Ejection Fraction During Follow-Up in Patients With Primary Prevention Implantable Cardioverter Defibrillators.Am J Cardiol. 2017 Jul 15;120(2):279-286. doi: 10.1016/j.amjcard.2017.04.020. Epub 2017 Apr 27. Am J Cardiol. 2017. PMID: 28532779 Review.
Cited by
-
Downgrade of cardiac defibrillator devices to pacemakers in elderly heart failure patients: clinical considerations and the importance of shared decision-making.Neth Heart J. 2021 May;29(5):243-252. doi: 10.1007/s12471-021-01555-w. Epub 2021 Mar 12. Neth Heart J. 2021. PMID: 33710494 Free PMC article. Review.
References
-
- Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Rev Esp Cardiol. 2014;67:58. - PubMed
-
- Di Biase L, Gasparini M, Lunati M, et al. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy. the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry. J Am Coll Cardiol. 2008;52:1442–1449. doi: 10.1016/j.jacc.2008.07.043. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials